[go: up one dir, main page]

CN116555033A - A mold and a method for arraying and growing muscle stem cells and their application - Google Patents

A mold and a method for arraying and growing muscle stem cells and their application Download PDF

Info

Publication number
CN116555033A
CN116555033A CN202310781190.4A CN202310781190A CN116555033A CN 116555033 A CN116555033 A CN 116555033A CN 202310781190 A CN202310781190 A CN 202310781190A CN 116555033 A CN116555033 A CN 116555033A
Authority
CN
China
Prior art keywords
cell
culture
cells
concentration
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310781190.4A
Other languages
Chinese (zh)
Inventor
陈启和
娄行行
刘东红
徐恩波
张圣良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN202310781190.4A priority Critical patent/CN116555033A/en
Publication of CN116555033A publication Critical patent/CN116555033A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/20Material Coatings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/46Means for fastening
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/003D culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/56Fibrin; Thrombin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Clinical Laboratory Science (AREA)
  • Sustainable Development (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides a mould, a method for arranging and growing muscle stem cells and application thereof, belonging to the technical field of cell culture; the die comprises a groove and needle-shaped assemblies vertically inserted into two ends of the groove. In the invention, the groove is used for containing gel; the needle-shaped component is used for fixing the gel, and after the two ends of the gel are fixed, the cells are mechanically acted, and grow towards the fixed direction, so that the directionality of the cell growth is controlled. The invention can realize the arrangement growth of cells in three-dimensional culture by utilizing the mould formed by combining the grooves and the needle-shaped components, wherein the needle-shaped components have a certain anchoring effect, can control the directionality of cell growth, and enable the growth and differentiation of muscle stem cells into orderly arranged myotube tissues. The invention realizes the arrangement, growth and differentiation of the fish muscle satellite cells in a three-dimensional environment for the first time, and promotes the development of cell culture fish meat.

Description

一种模具和一种肌肉干细胞排列生长的方法及其应用A mold and a method for arraying and growing muscle stem cells and their application

技术领域technical field

本发明属于细胞培养技术领域,具体涉及一种模具和一种肌肉干细胞排列生长的方法及其应用。The invention belongs to the technical field of cell culture, and in particular relates to a mold, a method for arraying and growing muscle stem cells and an application thereof.

背景技术Background technique

人造肉是一种替代蛋白质来源,是为了满足未来人们对肉类蛋白质的需求和缓解畜牧业带来的环境压力而出现的新兴产品。严格来说,目前人造肉并无十分清晰的定义,大部分国家归类于“肉类替代品”。而“人造肉”主要分为两大类,一类是以高含量植物蛋白为主要成分的植物肉(Plant-basedMeat),另一类是利用动物干细胞培养的细胞培养肉(Culturedmeat)。由于细胞在体外培养过程中模仿细胞在体内生长和分化的过程,从而可以生产出与传统肉制品具有相同营养和感官特性的产品。Artificial meat is an alternative protein source, and it is an emerging product to meet the future demand for meat protein and alleviate the environmental pressure brought by animal husbandry. Strictly speaking, there is no very clear definition of artificial meat at present, and most countries are classified as "meat substitutes". The "artificial meat" is mainly divided into two categories, one is plant-based meat (Plant-based Meat) with high content of plant protein as the main component, and the other is cell cultured meat (Cultured meat) cultivated by animal stem cells. Since the cells are cultured in vitro to mimic the process of cell growth and differentiation in vivo, it is possible to produce products with the same nutritional and organoleptic properties as traditional meat products.

早在20世纪30年代,就有研究学者提出了细胞培养肉的概念。2002年第一次进行了细胞培养肉的演示。2013年,MarkPost博士团队利用牛成肌细胞培养出第一块人造牛排并将其制作成汉堡包,但是其成本很高(重85克,价格约33万美元)。2016年,美国食品技术公司Mem-phisMeats全球首次研制出人造牛肉丸和人造鸡肉。2019年,南京农业大学周光宏团队等对猪肌肉干细胞进行培养获得了中国第一块人造肉。如今,越来越多的公司(截至2021年中期至少有70家)正在努力将细胞培养肉商业化和扩大规模,但是还面临着许多挑战。其中要使细胞培养肉在营养、口感和风味方面与真实肉制品更接近就是一个大的挑战,也是未来人造肉的主要研究发展方向。As early as the 1930s, some researchers proposed the concept of cell cultured meat. The first demonstration of cell-cultured meat took place in 2002. In 2013, Dr. MarkPost's team used bovine myoblasts to grow the first artificial steak and make it into a hamburger, but the cost was high (85 grams, about $330,000). In 2016, Mem-phis Meats, an American food technology company, developed artificial beef balls and artificial chicken for the first time in the world. In 2019, Zhou Guanghong's team at Nanjing Agricultural University and others cultivated pig muscle stem cells to obtain China's first piece of artificial meat. Today, a growing number of companies (at least 70 by mid-2021) are working to commercialize and scale up cell-based meat, but many challenges lie ahead. Among them, it is a big challenge to make cell-cultured meat closer to real meat products in terms of nutrition, taste and flavor, and it is also the main research and development direction of artificial meat in the future.

为了开发与真实肉类相似的细胞培养肉,有必要考虑自然产生的肌肉组织的结构。在大部分可食用的脊椎动物(猪,牛,鸡,鱼等)中存在三种肌肉组织,分别为骨骼肌、平滑肌和心脏肌肉,其中骨骼肌是动物机体中最大组织,是肉的重要来源。骨骼肌的主要功能单位是肌肉纤维(也称为肌细胞);肌肉纤维被组织成束,称为肌束;肌束再被组织成肌肉。排列整齐的肌肉纤维、脂肪、结构化的结缔组织和肌肉的其他结构元素共同产生了其机械特性,如果将肌肉作为肉食用,则这些特性被视为质地。因此,排列整齐的肌肉纤维是肌肉组织的一大特点。因此有必要开发出一种装置和/或方法来实现肌肉干细胞在三维培养条件下排列生长。In order to develop cell-cultured meat that resembles real meat, it is necessary to consider the structure of naturally occurring muscle tissue. In most edible vertebrates (pigs, cattle, chickens, fish, etc.), there are three kinds of muscle tissues, namely skeletal muscle, smooth muscle and heart muscle, among which skeletal muscle is the largest tissue in the animal body and is an important source of meat . The main functional unit of skeletal muscle is the muscle fiber (also called myocyte); the muscle fiber is organized into bundles called fascicles; the muscle bundles are organized into muscles. The well-aligned muscle fibers, fat, structured connective tissue, and other structural elements of muscle combine to produce its mechanical properties, which would be considered texture if muscle were eaten as meat. Therefore, well-arranged muscle fibers are a major feature of muscle tissue. Therefore, it is necessary to develop a device and/or method to realize the arrangement and growth of muscle stem cells under three-dimensional culture conditions.

发明内容Contents of the invention

本发明的目的在于提供一种模具和一种肌肉干细胞排列生长的方法及其应用,利用所述模具能够使肌肉干细胞在三维环境下排列生长。The object of the present invention is to provide a mold and a method for arranging and growing muscle stem cells and its application. Using the mold, the muscle stem cells can be arranged and grown in a three-dimensional environment.

本发明提供了一种模具,包括凹槽和竖向插入所述凹槽两端的针形组件。The present invention provides a mold, which includes a groove and needle-shaped components vertically inserted into two ends of the groove.

优选的,所述凹槽的材质包括硅胶;所述凹槽的形状包括U型。Preferably, the material of the groove includes silica gel; the shape of the groove includes U-shape.

优选的,所述针形组件包括大头针;所述针形组件的间距为3~9mm。Preferably, the needle-shaped components include pins; the distance between the needle-shaped components is 3-9mm.

本发明还提供了一种肌肉干细胞排列生长的方法,包括以下步骤:The present invention also provides a method for arraying and growing muscle stem cells, comprising the following steps:

1)将肌肉干细胞的细胞悬液、预凝胶基质和凝血酶混合,得到混合悬液;1) mixing the cell suspension of the muscle stem cells, the pregel matrix and thrombin to obtain a mixed suspension;

2)将所述混合悬液加入到无菌的上述方案所述的模具中,凝固形成细胞纤维蛋白水凝胶;2) adding the mixed suspension into the aseptic mold described in the above scheme, solidifying to form cell fibrin hydrogel;

3)在所述细胞纤维蛋白水凝胶中加入增殖培养基,进行细胞培养;3) adding a proliferation medium to the cell fibrin hydrogel for cell culture;

所述预凝胶基质以DMEM高糖培养基为基础,还包含纤维蛋白原和抗生素。The pregel matrix is based on DMEM high glucose medium and also contains fibrinogen and antibiotics.

优选的,所述混合悬液中纤维蛋白原的浓度为8~10mg/mL。Preferably, the concentration of fibrinogen in the mixed suspension is 8-10 mg/mL.

优选的,所述混合悬液中肌肉干细胞的浓度为4×106~9×106个/mL;所述混合悬液中凝血酶的浓度为4~5U/mL。Preferably, the concentration of muscle stem cells in the mixed suspension is 4×10 6 to 9×10 6 cells/mL; the concentration of thrombin in the mixed suspension is 4 to 5 U/mL.

优选的,所述抗生素包括青霉素G钠盐和硫酸链霉素;所述预凝胶基质中青霉素G钠盐的浓度为100U/mL;所述预凝胶基质中硫酸链霉素的浓度为0.1mg/mL。Preferably, the antibiotics include penicillin G sodium salt and streptomycin sulfate; the concentration of penicillin G sodium salt in the pregel matrix is 100U/mL; the concentration of streptomycin sulfate in the pregel matrix is 0.1 mg/mL.

优选的,所述凝固的条件包括:温度为25~27℃,CO2的体积浓度为4%~6%,时间为20~60min。Preferably, the coagulation conditions include: the temperature is 25-27° C., the volume concentration of CO 2 is 4%-6%, and the time is 20-60 minutes.

优选的,所述细胞培养的温度为25~27℃;所述细胞培养的CO2的体积浓度为4%~6%;所述细胞培养包括依次进行的增殖培养和分化培养;所述增殖培养的时间为3~5d;所述分化培养的时间为6~8d。Preferably, the temperature of the cell culture is 25-27°C; the volume concentration of CO 2 in the cell culture is 4%-6%; the cell culture includes sequential proliferation culture and differentiation culture; the proliferation culture The time for the differentiation culture is 3-5 days; the time for the differentiation culture is 6-8 days.

本发明还提供了上述方案所述的模具或者所述的方法在制备细胞培养肉中的应用。The present invention also provides the application of the mold described in the above scheme or the method described in the preparation of cell culture meat.

本发明提供了一种模具,包括凹槽和竖向插入所述凹槽两端的针形组件。在本发明中,所述凹槽用于盛装凝胶;所述针形组件用于固定凝胶,将凝胶两端固定之后,细胞受到机械作用,就会朝着固定的方向生长,从而控制细胞生长的方向性。本发明利用凹槽和针形组件组合成的模具能够实现三维培养中细胞的排列生长,其中针形组件有一定的锚定作用,可以控制细胞生长的方向性,使肌肉干细胞生长分化为排列整齐的肌管组织。本发明首次实现了鱼肌卫星细胞在三维环境中的排列生长分化,推动了细胞培养鱼肉的发展。The present invention provides a mold, which includes a groove and needle-shaped components vertically inserted into two ends of the groove. In the present invention, the groove is used to hold the gel; the needle-shaped assembly is used to fix the gel. After the two ends of the gel are fixed, the cells will grow towards the fixed direction under mechanical action, thereby controlling directionality of cell growth. In the present invention, the mold composed of grooves and needle-shaped components can realize the arrangement and growth of cells in three-dimensional culture, wherein the needle-shaped components have a certain anchoring effect, can control the directionality of cell growth, and make the growth and differentiation of muscle stem cells into an orderly arrangement. of myotube tissue. The invention realizes the arrangement, growth and differentiation of fish muscle satellite cells in a three-dimensional environment for the first time, and promotes the development of cell cultured fish meat.

附图说明Description of drawings

为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the following will briefly introduce the accompanying drawings required in the embodiments. Obviously, the accompanying drawings in the following description are only some of the present invention. Embodiments, for those of ordinary skill in the art, other drawings can also be obtained according to these drawings without paying creative labor.

图1为实施例和对比例中细胞三维培养模型对比,其中,A:硅胶管模型培养,B:圆滴状培养;Figure 1 is a comparison of three-dimensional cell culture models in Examples and Comparative Examples, wherein, A: silicone tube model culture, B: round drop culture;

图2为实施例1中分化7天后的免疫荧光染色图,从左到右依次为结蛋白免疫荧光染色图、细胞核免疫荧光染色图和结蛋白/细胞核组合图;Figure 2 is the immunofluorescence staining diagram after 7 days of differentiation in Example 1, from left to right are desmin immunofluorescence staining diagram, cell nucleus immunofluorescence staining diagram and desmin/nucleus combined diagram;

图3为实施例2中分化7天后的免疫荧光染色图,从左到右依次为结蛋白免疫荧光染色图、细胞核免疫荧光染色图和结蛋白/细胞核组合图;Figure 3 is the immunofluorescence staining diagram after 7 days of differentiation in Example 2, from left to right are desmin immunofluorescence staining diagram, cell nucleus immunofluorescence staining diagram and desmin/nucleus combined diagram;

图4为实施例3中分化7天后的免疫荧光染色图,从左到右依次为结蛋白免疫荧光染色图、细胞核免疫荧光染色图和结蛋白/细胞核组合图;Figure 4 is the immunofluorescence staining diagram after 7 days of differentiation in Example 3, from left to right are desmin immunofluorescence staining diagram, cell nucleus immunofluorescence staining diagram and desmin/nucleus combined diagram;

图5为对比例1中分化7天后的免疫荧光染色图,从左到右依次为结蛋白免疫荧光染色图、细胞核免疫荧光染色图和结蛋白/细胞核组合图;Figure 5 is the immunofluorescence staining diagram after 7 days of differentiation in Comparative Example 1, from left to right are desmin immunofluorescence staining diagram, cell nucleus immunofluorescence staining diagram and desmin/nuclei combination diagram;

图6为对比例2中分化7天后的免疫荧光染色图,从左到右依次为结蛋白免疫荧光染色图、细胞核免疫荧光染色图和结蛋白/细胞核组合图;Figure 6 is the immunofluorescence staining diagram after 7 days of differentiation in Comparative Example 2, from left to right are desmin immunofluorescence staining diagram, cell nucleus immunofluorescence staining diagram and desmin/nucleus combination diagram;

图7为对比例3中分化7天后的免疫荧光染色图,从左到右依次为结蛋白免疫荧光染色图、细胞核免疫荧光染色图和结蛋白/细胞核组合图。Fig. 7 is the immunofluorescence staining image after 7 days of differentiation in Comparative Example 3, from left to right is desmin immunofluorescence staining image, cell nucleus immunofluorescence staining image and desmin/nucleus combined image.

具体实施方式Detailed ways

本发明提供了一种模具,包括凹槽和竖向插入所述凹槽两端的针形组件。The present invention provides a mold, which includes a groove and needle-shaped components vertically inserted into two ends of the groove.

在本发明中,所述凹槽的材质包括硅胶,其他的生物安全级别、可灭菌、可安装固定支架、可盛装水凝胶的材料也可以替代硅胶;所述凹槽的形状包括U型;所述凹槽的横切面的形状优选为半圆形;所述凹槽用于盛装凝胶。In the present invention, the material of the groove includes silica gel, and other biosafety grades, materials that can be sterilized, can be installed with fixed brackets, and can contain hydrogel can also replace silica gel; the shape of the groove includes U-shaped ; The shape of the cross section of the groove is preferably a semicircle; The groove is used to hold the gel.

在本发明中,所述针形组件的间距优选为3~9mm;所述针形组件的材质优选为不锈钢或非金属材质;所述非金属材质优选的包括塑料;所述针形组件的长度优选为10mm;所述针形组件的直径优选为0.7mm;所述竖向插入优选为垂直插入;所述针形组件优选为大头针;针形组件竖向插入所述凹槽两端形成固定点,起到锚定作用,用于固定凝胶,将凝胶两端固定之后,细胞受到机械作用,就会朝着固定的方向生长,从而控制细胞生长的方向性。In the present invention, the pitch of the needle-shaped components is preferably 3-9mm; the material of the needle-shaped components is preferably stainless steel or non-metallic material; the non-metallic material preferably includes plastic; the length of the needle-shaped components Preferably 10mm; the diameter of the needle assembly is preferably 0.7mm; the vertical insertion is preferably vertical insertion; the needle assembly is preferably a pin; the needle assembly is vertically inserted into both ends of the groove to form a fixed point , which acts as an anchor and is used to fix the gel. After the two ends of the gel are fixed, the cells will grow in a fixed direction under mechanical action, thereby controlling the directionality of cell growth.

在本发明中,所述模具的制备方法,优选的包括以下步骤:In the present invention, the preparation method of the mold preferably comprises the following steps:

将硅胶管纵向切成两半,得到凹槽;Cut the silicone tube in half lengthwise to get grooves;

在所述凹槽的两端竖向插入大头针,得到模具。Insert pins vertically at both ends of the groove to obtain a mold.

在本发明中,所述硅胶管优选为食品级硅胶管;所述硅胶管的内径优选为3.2mm;所述硅胶管的外径优选为6.4mm;所述硅胶管来源于常规市售。在本发明的具体实施过程中,所述硅胶管网购于润泽旗舰店。In the present invention, the silicone tube is preferably a food-grade silicone tube; the inner diameter of the silicone tube is preferably 3.2 mm; the outer diameter of the silicone tube is preferably 6.4 mm; the silicone tube is from conventional commercially available sources. During the specific implementation of the present invention, the silicone tube was purchased online at the Runze flagship store.

在将所述硅胶管纵向切成两半前,本发明优选的还包括将硅胶管横向剪成硅胶管段;所述凹槽的长度优选为12~18mm,更优选为15mm,此长度是针对于模型放置于24孔板培养长度,若为其他孔板培养,长度则依据孔板直径所改变。Before the silicone tube is longitudinally cut into two halves, the present invention preferably also includes cutting the silicone tube transversely into silicone tube sections; the length of the groove is preferably 12-18mm, more preferably 15mm, and this length is for The model is placed in a 24-well plate for culture length. If it is cultured in other well plates, the length will be changed according to the diameter of the well plate.

在得到模具后,本发明优选的还包括对所述模具进行灭菌;所述灭菌的方式优选的包括将所述模具置于体积浓度为75%的乙醇水溶液中进行灭菌;在所述灭菌后,本发明优选的还包括对所述灭菌后的模具进行清洗;所述清洗采用的试剂优选为无菌PBS;在所述清洗后,本发明优选的还包括将清洗后的模具进行干燥;所述干燥的方式优选为于无菌环境中晾干。在本发明的具体实施过程中,所述无菌环境优选为开着紫外的超净工作台。After obtaining the mould, the present invention preferably also includes sterilizing the mould; the sterilizing method preferably includes placing the mould in an aqueous ethanol solution with a volume concentration of 75% for sterilization; After the sterilization, the present invention preferably also includes cleaning the sterilized mold; the reagent used in the cleaning is preferably sterile PBS; after the cleaning, the present invention preferably also includes cleaning the mold Drying; the drying method is preferably air drying in a sterile environment. In the specific implementation process of the present invention, the sterile environment is preferably a ultra-clean workbench with ultraviolet light turned on.

本发明还提供了一种肌肉干细胞排列生长的方法,包括以下步骤:The present invention also provides a method for arraying and growing muscle stem cells, comprising the following steps:

1)将肌肉干细胞的细胞悬液、预凝胶基质和凝血酶混合,得到混合悬液;1) mixing the cell suspension of the muscle stem cells, the pregel matrix and thrombin to obtain a mixed suspension;

2)将所述混合悬液加入到无菌的上述方案所述的模具中,凝固形成细胞纤维蛋白水凝胶;2) adding the mixed suspension into the aseptic mold described in the above scheme, solidifying to form cell fibrin hydrogel;

3)在所述细胞纤维蛋白水凝胶中加入增殖培养基,进行细胞培养;3) adding a proliferation medium to the cell fibrin hydrogel for cell culture;

所述预凝胶基质以DMEM高糖培养基为基础,还包含纤维蛋白原和抗生素。The pregel matrix is based on DMEM high glucose medium and also contains fibrinogen and antibiotics.

本发明首先将肌肉干细胞的细胞悬液、预凝胶基质和凝血酶混合,得到混合悬液。In the invention, firstly, the cell suspension of muscle stem cells, the pregel matrix and thrombin are mixed to obtain a mixed suspension.

在本发明中,所述肌肉干细胞优选为来源于鱼的肌肉干细胞;所述来源于鱼的肌肉干细胞优选为鱼肌卫星细胞;所述鱼肌卫星细胞优选为大黄鱼肌卫星细胞;所述大黄鱼肌卫星细胞优选的分离自大黄鱼肌肉组织;所述大黄鱼优选为幼鱼;所述大黄鱼肌肉组织优选为大黄鱼肌上轴部位分离得到肌肉组织。本发明对所述大黄鱼肌卫星细胞的来源和分离方法没有特殊限制。In the present invention, the muscle stem cells are preferably muscle stem cells derived from fish; the muscle stem cells derived from fish are preferably fish muscle satellite cells; the fish muscle satellite cells are preferably large yellow croaker muscle satellite cells; The yellow croaker muscle satellite cells are preferably isolated from large yellow croaker muscle tissue; the large yellow croaker muscle tissue is preferably juvenile; the large yellow croaker muscle tissue is preferably muscle tissue isolated from the upper axis of the large yellow croaker muscle. The present invention has no special limitation on the source and isolation method of the large yellow croaker muscle satellite cells.

在本发明中,所述将肌肉干细胞的细胞悬液、预凝胶基质和凝血酶混合优选的包括现将肌肉干细胞的细胞悬液、预凝胶基质混合,得到混合物;再将所述混合物和凝血酶混合。In the present invention, the mixing of the cell suspension of muscle stem cells, the pre-gel matrix and thrombin preferably includes mixing the cell suspension of muscle stem cells and the pre-gel matrix to obtain a mixture; Thrombin mix.

在本发明中,所述混合悬液中肌肉干细胞的浓度优选为4×106~9×106个/mL。在本发明中,所述混合悬液中纤维蛋白原的浓度优选为8~10mg/mL;所述混合悬液中凝血酶的浓度优选为4~5U/mL。在本发明中,所述抗生素优选的包括青霉素G钠盐和硫酸链霉素;所述预凝胶基质中青霉素G钠盐的浓度为100U/mL;所述预凝胶基质中硫酸链霉素的浓度为0.1mg/mL。In the present invention, the concentration of muscle stem cells in the mixed suspension is preferably 4×10 6 -9×10 6 cells/mL. In the present invention, the concentration of fibrinogen in the mixed suspension is preferably 8-10 mg/mL; the concentration of thrombin in the mixed suspension is preferably 4-5 U/mL. In the present invention, the antibiotic preferably includes penicillin G sodium salt and streptomycin sulfate; the concentration of penicillin G sodium salt in the pregel matrix is 100U/mL; The concentration is 0.1mg/mL.

得到混合悬液后,本发明将所述混合悬液加入到无菌的上述方案所述的模具中,凝固形成细胞纤维蛋白水凝胶。After the mixed suspension is obtained, the present invention adds the mixed suspension into the aseptic mold described in the above scheme, and solidifies to form the cell fibrin hydrogel.

在本发明中,以凹槽的长度为15mm、深度为1.5mm计,将混合悬液加入到无菌的上述方案所述的模具中的体积优选为50~80μL,更优选为60~70μL。In the present invention, based on the groove length being 15 mm and depth being 1.5 mm, the volume of adding the mixed suspension into the aseptic mold described in the above scheme is preferably 50-80 μL, more preferably 60-70 μL.

在本发明中,所述凝固的条件优选的包括:温度为25~27℃,CO2的体积浓度为4%~6%,时间为20~60min。In the present invention, the coagulation conditions preferably include: the temperature is 25-27° C., the volume concentration of CO 2 is 4%-6%, and the time is 20-60 minutes.

本发明中所使用的材料为纤维蛋白水凝胶,具有优良的生物相容性,可供细胞增殖和分化,而采用胶原蛋白水凝胶有断裂的风险。The material used in the present invention is fibrin hydrogel, which has excellent biocompatibility and can be used for cell proliferation and differentiation, while collagen hydrogel has the risk of breaking.

形成细胞纤维蛋白水凝胶后,本发明在所述细胞纤维蛋白水凝胶中加入增殖培养基,进行细胞培养。After the cell fibrin hydrogel is formed, the present invention adds a proliferation medium to the cell fibrin hydrogel for cell culture.

在本发明中,所述细胞培养的温度优选为25~27℃,更优选为26℃;所述细胞培养的CO2的体积浓度优选为4%~6%,优选为5%;所述细胞培养优选的包括依次进行的增殖培养和分化培养;所述增殖培养的时间优选为3~5d,更优选为4d;所述分化培养的时间优选为6~8d,更优选为7d。In the present invention, the temperature of the cell culture is preferably 25-27°C, more preferably 26°C; the volume concentration of CO2 for the cell culture is preferably 4%-6%, preferably 5%; the cell The culture preferably includes sequential proliferation culture and differentiation culture; the time of the proliferation culture is preferably 3-5 days, more preferably 4 days; the time of the differentiation culture is preferably 6-8 days, more preferably 7 days.

在本发明中,所述增殖培养采用的增殖培养基以DMEM高糖培养基为基础培养基,优选的还包括以下浓度的组分:体积浓度为10%的胎牛血清、10ng/mL人重组碱性成纤维细胞生长因子、100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素。在本发明中,所述分化培养采用的分化培养基以DMEM/F12培养基为基础培养基,优选的还包括以下浓度的组分:体积浓度为8%的马血清、10ng/mL人重组胰岛素样生长因子-1、50nMnecrosulfonamide、200μM抗坏血酸、100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素。In the present invention, the proliferation medium used in the proliferation culture is based on DMEM high-glucose medium, and preferably also includes components at the following concentrations: fetal bovine serum with a volume concentration of 10%, 10ng/mL human recombinant Basic fibroblast growth factor, 100 U/mL penicillin G sodium salt and 0.1 mg/mL streptomycin sulfate. In the present invention, the differentiation medium used in the differentiation culture is based on DMEM/F12 medium, and preferably also includes the following components at concentrations: horse serum with a volume concentration of 8%, 10ng/mL human recombinant insulin Like growth factor-1, 50nMnecrosulfonamide, 200μM ascorbic acid, 100U/mL penicillin G sodium salt and 0.1mg/mL streptomycin sulfate.

本发明还提供了上述方案所述的模具或者所述的方法在制备细胞培养肉中的应用。在本发明中,所述细胞培养肉优选的包括细胞培养鱼肉。The present invention also provides the application of the mold described in the above scheme or the method described in the preparation of cell culture meat. In the present invention, the cell-cultured meat preferably includes cell-cultured fish.

为了进一步说明本发明,下面结合附图和实施例对本发明提供的一种模具和一种肌肉干细胞排列生长的方法及其应用进行详细地描述,但不能将它们理解为对本发明保护范围的限定。In order to further illustrate the present invention, a mold provided by the present invention and a method for arraying and growing muscle stem cells and their applications are described in detail below in conjunction with the accompanying drawings and examples, but they should not be construed as limiting the protection scope of the present invention.

下面结合具体实施例对本发明做进一步说明。以下实施例仅用于说明本发明,不用来限制本发明的适用范围。在不背离本发明精神和本质的情况下,对本发明方法、步骤或条件所做的修改或替换,均属于本发明的范围。The present invention will be further described below in conjunction with specific embodiments. The following examples are only used to illustrate the present invention, and are not intended to limit the scope of application of the present invention. Without departing from the spirit and essence of the present invention, any modifications or substitutions made to the methods, steps or conditions of the present invention belong to the scope of the present invention.

下述实施例中所使用的试验方法如无特殊说明,均为常规方法;所使用的材料、试剂等,如无特殊说明,为可从商业途径得到的试剂和材料。The test methods used in the following examples are conventional methods unless otherwise specified; the materials and reagents used are commercially available reagents and materials unless otherwise specified.

DMEM高糖培养基(BL304A,Biosharp),DMEM/F12培养基(PM150312,Procell);胎牛血清(WISENT);马血清(BL209A,Biosharp);人重组碱性成纤维细胞生长因子(P5453-10μg,碧云天);人重组胰岛素样生长因子-1(P00048,索莱宝);necrosulfonamide(N872612-5mg,麦克林);抗坏血酸(A103534-100g,阿拉丁);100×抗生素(P1400,索莱宝);DMEM high glucose medium (BL304A, Biosharp), DMEM/F12 medium (PM150312, Procell); fetal bovine serum (WISENT); horse serum (BL209A, Biosharp); human recombinant basic fibroblast growth factor (P5453-10μg , Biyuntian); human recombinant insulin-like growth factor-1 (P00048, Suo Lai Bao); necrosulfonamide (N872612-5mg, McLean); ascorbic acid (A103534-100g, Aladdin); 100 × antibiotics (P1400, Su Lai Bao );

其他试剂:纤维蛋白原(BS943-1g,Biosharp);凝血酶(BS903-1000u,Biosharp);Ⅳ型胶原酶(17104019,Gibco);Other reagents: fibrinogen (BS943-1g, Biosharp); thrombin (BS903-1000u, Biosharp); type IV collagenase (17104019, Gibco);

下述实例采用的鱼肌卫星为大黄鱼肌卫星细胞。大黄鱼肌卫星细胞原代细胞为实验室采用常规方法制备所得,从大黄鱼幼鱼肌上轴部位分离得到肌肉组织,然后分别用0.1%IV型胶原酶溶液和0.1%胰蛋白酶溶液消化,消化后的组织分别用70μm和40μm细胞筛过滤,300g离心5min,用完全培养基重悬细胞沉淀,之后按1×106个细胞/mL的浓度接种在6孔板中,放置在培养条件为27℃、5%CO2的培养箱中培养。The fish muscle satellites used in the following examples are large yellow croaker muscle satellite cells. The primary cells of large yellow croaker muscle satellite cells are prepared by conventional methods in the laboratory. The muscle tissue is isolated from the upper axis of the juvenile large yellow croaker muscle, and then digested with 0.1% type IV collagenase solution and 0.1% trypsin solution respectively. The obtained tissues were filtered with 70 μm and 40 μm cell sieves respectively, centrifuged at 300 g for 5 min, and the cell pellet was resuspended with complete medium, and then inoculated in a 6-well plate at a concentration of 1×10 6 cells/mL, and placed in a culture condition of 27 Cultivate in an incubator with 5% CO2 .

实施例1Example 1

首先取规格为3.2*6.4mm(内径*外径)的进口食品级硅胶管,用剪刀将其剪成约15mm长的小段,再利用刀片将其切成两半(纵向),得到具有凹槽的腔室体系;将长10mm,直径0.7mm的不锈钢大头针插入管中作为固定点,针之间的距离为8mm。制作完毕后,将其放入75%乙醇中进行杀菌,杀菌完毕后用无菌PBS进行清洗,最后放入24孔板中晾干待用。First, take an imported food-grade silicone tube with a specification of 3.2*6.4mm (inner diameter*outer diameter), cut it into small sections about 15mm long with scissors, and then cut it in half (longitudinal) with a blade to obtain a grooved tube. The chamber system; stainless steel pins with a length of 10 mm and a diameter of 0.7 mm were inserted into the tube as fixed points, and the distance between the pins was 8 mm. After the preparation is completed, put it into 75% ethanol for sterilization, wash it with sterile PBS after the sterilization, and finally put it into a 24-well plate to dry for use.

然后在无菌条件下利用含有1×抗生素的DMEM高糖溶液配制纤维蛋白原母液和凝血酶母液,浓度分别为50mg/mL和200U/mL,保存在4℃冰箱中待用。Then, under aseptic conditions, the fibrinogen mother solution and the thrombin mother solution were prepared with DMEM high-sugar solution containing 1×antibiotics, the concentrations were 50mg/mL and 200U/mL, respectively, and stored in a refrigerator at 4°C until use.

选取生长状态良好的鱼肌卫星细胞,待细胞汇合达到80%时,加入胰蛋白酶进行消化、离心,收集细胞并计数。取纤维蛋白原母液160μL加入300μL含有1×抗生素(100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素)的DMEM高糖培养基,再加入320μL细胞悬液,最后加入20μL凝血酶母液,添加完毕后用移液枪上下吹打混合均匀。整个体系800μL,最终的纤维蛋白原浓度为10mg/mL,凝血酶浓度为5U/mL,细胞浓度为9.0×106个/mL。Fish muscle satellite cells in good growth state were selected, and when the cell confluence reached 80%, trypsin was added for digestion, centrifuged, and the cells were collected and counted. Take 160 μL of fibrinogen mother solution and add 300 μL of DMEM high-glucose medium containing 1× antibiotics (100 U/mL penicillin G sodium salt and 0.1 mg/mL streptomycin sulfate), then add 320 μL of cell suspension, and finally add 20 μL of thrombin mother solution After the addition, pipette up and down with a pipette to mix evenly. The whole system was 800 μL, the final concentration of fibrinogen was 10 mg/mL, the concentration of thrombin was 5 U/mL, and the concentration of cells was 9.0×10 6 cells/mL.

取60μL上述所得的细胞-纤维蛋白原悬液添加到24孔板中的硅胶管模板中,于27℃、体积份数为5%的CO2细胞培养箱中放置40min使纤维蛋白原凝固。然后加入1000μL增殖培养基再放入培养箱进行培养。增殖培养3天,在第3天更换分化培养基,接着分化培养7天,每两天更换一次培养基。分化培养第七天,对包含细胞的纤维蛋白水凝胶进行免疫荧光染色。Take 60 μL of the cell-fibrinogen suspension obtained above and add it to the silica gel tube template in a 24-well plate, and place it in a 5% CO2 cell culture incubator at 27°C for 40 minutes to solidify the fibrinogen. Then add 1000 μL of proliferation medium and put it into the incubator for cultivation. Proliferation culture was performed for 3 days, and the differentiation medium was replaced on the third day, followed by differentiation culture for 7 days, and the medium was replaced every two days. On the seventh day of differentiation culture, immunofluorescent staining was performed on the fibrin hydrogels containing the cells.

其中增殖培养基为含有10%胎牛血清、10ng/mL人重组碱性成纤维细胞生长因子、1×抗生素(100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素)的DMEM高糖培养基;分化培养基为含有8%马血清、10ng/mL人重组胰岛素样生长因子-1、50nMnecrosulfonamide、200μM抗坏血酸、1×抗生素(100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素)的DMEM/F12培养基。The proliferation medium is DMEM high glucose containing 10% fetal bovine serum, 10 ng/mL human recombinant basic fibroblast growth factor, 1× antibiotics (100 U/mL penicillin G sodium salt and 0.1 mg/mL streptomycin sulfate) Medium; Differentiation medium is containing 8% horse serum, 10ng/mL human recombinant insulin-like growth factor-1, 50nMnecrosulfonamide, 200μM ascorbic acid, 1× antibiotics (100U/mL penicillin G sodium salt and 0.1mg/mL streptomycin sulfate ) of DMEM/F12 medium.

本实施例中利用硅胶管模板所培养的细胞如图1中的A。分化第七天的细胞-纤维蛋白水凝胶的免疫荧光染色图如图2所示,结蛋白/细胞核染色可以看出鱼肌卫星细胞在纤维蛋白水凝胶中分化形成了肌管,并且肌管都有序排列,具有一定的方向性。In this example, the cells cultured using the silicone tube template are shown in A in Figure 1 . The immunofluorescence staining image of cells-fibrin hydrogel on the seventh day of differentiation is shown in Figure 2. Desmin/nucleus staining shows that fish muscle satellite cells have differentiated into myotubes in fibrin hydrogel, and muscle The tubes are arranged in an orderly manner and have a certain directionality.

实施例2Example 2

首先取规格为3.2*6.4mm(内径*外径)的进口食品级硅胶管,用剪刀将其剪成约15mm长的小段,再利用刀片将其切成两半(纵向),得到具有凹槽的腔室体系;将长10mm,直径0.7mm为不锈钢大头针插入管中作为固定点,针之间的距离为6mm。制作完毕后,将其放入75%乙醇中进行杀菌,杀菌完毕后用无菌PBS进行清洗,最后放入24孔板中晾干待用。First, take an imported food-grade silicone tube with a specification of 3.2*6.4mm (inner diameter*outer diameter), cut it into small sections about 15mm long with scissors, and then cut it in half (longitudinal) with a blade to obtain a grooved tube. A chamber system; a stainless steel pin with a length of 10 mm and a diameter of 0.7 mm was inserted into the tube as a fixed point, and the distance between the pins was 6 mm. After the preparation is completed, put it into 75% ethanol for sterilization, wash it with sterile PBS after the sterilization, and finally put it into a 24-well plate to dry for use.

然后在无菌条件下利用含有1×抗生素的DMEM/高糖溶液配制纤维蛋白原母液和凝血酶母液,浓度分别为50mg/mL和200U/mL,保存在4℃冰箱中待用。Then, under aseptic conditions, the fibrinogen mother solution and the thrombin mother solution were prepared with DMEM/high glucose solution containing 1×antibiotics, the concentrations were 50 mg/mL and 200 U/mL respectively, and they were stored in a refrigerator at 4°C until use.

选取生长状态良好的鱼肌卫星细胞,待细胞汇合达到80%时,加入胰蛋白酶进行消化、离心,收集细胞并计数。取纤维蛋白原母液128μL加入336μL含有1×抗生素的DMEM高糖培养基,再加入320μL细胞悬液,最后加入16μL凝血酶母液,添加完毕后用移液枪上下吹打混合均匀。整个体系800μL,最终的纤维蛋白原浓度为8mg/mL,凝血酶浓度为4U/mL,细胞浓度为9.0×106个/mL。Fish muscle satellite cells in good growth state were selected, and when the cell confluence reached 80%, trypsin was added for digestion, centrifuged, and the cells were collected and counted. Take 128 μL of fibrinogen mother solution and add 336 μL of DMEM high-glucose medium containing 1×antibiotics, then add 320 μL of cell suspension, and finally add 16 μL of thrombin mother solution. After adding, pipette up and down to mix evenly. The whole system was 800 μL, the final fibrinogen concentration was 8 mg/mL, the thrombin concentration was 4 U/mL, and the cell concentration was 9.0×10 6 cells/mL.

取50μL上述所得的细胞-纤维蛋白原悬液添加到24孔板中的硅胶管模板中,于27℃、5%CO2细胞培养箱中放置40min使纤维蛋白原凝固。然后加入1000μL增殖培养基再放入培养箱进行培养。增殖培养3天,在第3天更换分化培养基,接着分化培养7天,每两天更换一次培养基。分化培养第七天,对包含细胞的纤维蛋白水凝胶进行免疫荧光染色。Take 50 μL of the cell-fibrinogen suspension obtained above and add it to the silica gel tube template in a 24-well plate, and place it in a 27° C., 5% CO 2 cell culture incubator for 40 minutes to solidify the fibrinogen. Then add 1000 μL of proliferation medium and put it into the incubator for cultivation. Proliferation culture was performed for 3 days, and the differentiation medium was replaced on the third day, followed by differentiation culture for 7 days, and the medium was replaced every two days. On the seventh day of differentiation culture, immunofluorescent staining was performed on the fibrin hydrogels containing the cells.

其中增殖培养基为含有10%胎牛血清、10ng/mL人重组碱性成纤维细胞生长因子、1×抗生素(100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素)的DMEM高糖培养基;分化培养基为含有8%马血清、10ng/mL人重组胰岛素样生长因子-1、50nMnecrosulfonamide、200μM抗坏血酸、1×抗生素(100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素)的DMEM/F12培养基。The proliferation medium is DMEM high glucose containing 10% fetal bovine serum, 10 ng/mL human recombinant basic fibroblast growth factor, 1× antibiotics (100 U/mL penicillin G sodium salt and 0.1 mg/mL streptomycin sulfate) Medium; Differentiation medium is containing 8% horse serum, 10ng/mL human recombinant insulin-like growth factor-1, 50nMnecrosulfonamide, 200μM ascorbic acid, 1× antibiotics (100U/mL penicillin G sodium salt and 0.1mg/mL streptomycin sulfate ) of DMEM/F12 medium.

本实施例中分化第七天的细胞-纤维蛋白水凝胶的免疫荧光染色图如图3所示,结蛋白/细胞核染色可以看出鱼肌卫星细胞在纤维蛋白水凝胶中分化为排列整齐的肌管。In this example, the immunofluorescent staining of the cell-fibrin hydrogel on the seventh day of differentiation is shown in Figure 3. The desmin/nucleus staining shows that the fish muscle satellite cells are differentiated into fibrin hydrogel and arranged neatly. of myotubes.

实施例3Example 3

首先取规格为3.2*6.4mm(内径*外径)的进口食品级硅胶管,用剪刀将其剪成约15mm长的小段,再利用刀片将其切成两半(纵向),得到具有凹槽的腔室体系;将长10mm,直径0.7mm为不锈钢大头针插入管中作为固定点,针之间的距离为4mm。制作完毕后,将其放入75%乙醇中进行杀菌,杀菌完毕后用无菌PBS进行清洗,最后放入24孔板中晾干待用。First, take an imported food-grade silicone tube with a specification of 3.2*6.4mm (inner diameter*outer diameter), cut it into small sections about 15mm long with scissors, and then cut it in half (longitudinal) with a blade to obtain a grooved tube. A chamber system; stainless steel pins with a length of 10 mm and a diameter of 0.7 mm were inserted into the tube as fixed points, and the distance between the pins was 4 mm. After the preparation is completed, put it into 75% ethanol for sterilization, wash it with sterile PBS after the sterilization, and finally put it into a 24-well plate to dry for use.

然后在无菌条件下利用含有1×抗生素的DMEM/高糖溶液配制纤维蛋白原母液和凝血酶母液,浓度分别为50mg/mL和200U/mL,保存在4℃冰箱中待用。Then, under aseptic conditions, the fibrinogen mother solution and the thrombin mother solution were prepared with DMEM/high glucose solution containing 1×antibiotics, the concentrations were 50 mg/mL and 200 U/mL respectively, and they were stored in a refrigerator at 4°C until use.

选取生长状态良好的鱼肌卫星细胞,待细胞汇合达到80%时,加入胰蛋白酶进行消化、离心,收集细胞并计数。取纤维蛋白原母液160μL加入470μL含有1×抗生素的DMEM高糖培养基,再加入150μL细胞悬液,最后加入20μL凝血酶母液,添加完毕后用移液枪上下吹打混合均匀。整个体系800μL,最终的纤维蛋白原浓度为10mg/mL,凝血酶浓度为5U/mL,细胞浓度为4.0×106个/mL。Fish muscle satellite cells in good growth state were selected, and when the cell confluence reached 80%, trypsin was added for digestion, centrifuged, and the cells were collected and counted. Take 160 μL of fibrinogen mother solution and add 470 μL of DMEM high-glucose medium containing 1× antibiotics, then add 150 μL of cell suspension, and finally add 20 μL of thrombin mother solution. After the addition, pipette up and down to mix evenly. The whole system was 800 μL, the final concentration of fibrinogen was 10 mg/mL, the concentration of thrombin was 5 U/mL, and the concentration of cells was 4.0×10 6 cells/mL.

取50μL上述所得的细胞-纤维蛋白原悬液添加到24孔板中的硅胶管模板中,于27℃、5%CO2细胞培养箱中放置40min使纤维蛋白原凝固。然后加入1000μL增殖培养基再放入培养箱进行培养。增殖培养3天,在第3天更换分化培养基,接着分化培养7天,每两天更换一次培养基。分化培养第七天,对包含细胞的纤维蛋白水凝胶进行免疫荧光染色。Take 50 μL of the cell-fibrinogen suspension obtained above and add it to the silica gel tube template in a 24-well plate, and place it in a 27° C., 5% CO 2 cell culture incubator for 40 minutes to solidify the fibrinogen. Then add 1000 μL of proliferation medium and put it into the incubator for cultivation. Proliferation culture was performed for 3 days, and the differentiation medium was replaced on the third day, followed by differentiation culture for 7 days, and the medium was replaced every two days. On the seventh day of differentiation culture, immunofluorescent staining was performed on the fibrin hydrogels containing the cells.

其中增殖培养基为含有10%胎牛血清、10ng/mL人重组碱性成纤维细胞生长因子、1×抗生素(100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素)的DMEM高糖培养基;分化培养基为含有8%马血清、10ng/mL人重组胰岛素样生长因子-1、50nMnecrosulfonamide、200μM抗坏血酸、1×抗生素(100U/mL青霉素G钠盐和0.1mg/mL硫酸链霉素)的DMEM/F12培养基。The proliferation medium is DMEM high glucose containing 10% fetal bovine serum, 10 ng/mL human recombinant basic fibroblast growth factor, 1× antibiotics (100 U/mL penicillin G sodium salt and 0.1 mg/mL streptomycin sulfate) Medium; Differentiation medium is containing 8% horse serum, 10ng/mL human recombinant insulin-like growth factor-1, 50nMnecrosulfonamide, 200μM ascorbic acid, 1× antibiotics (100U/mL penicillin G sodium salt and 0.1mg/mL streptomycin sulfate ) of DMEM/F12 medium.

本实施例中分化第七天的细胞-纤维蛋白水凝胶的免疫荧光染色图如图4所示,结蛋白/细胞核染色可以看出鱼肌卫星细胞在纤维蛋白水凝胶中分化为排列整齐的肌管。In this example, the immunofluorescent staining of the cell-fibrin hydrogel on the seventh day of differentiation is shown in Figure 4. The desmin/nucleus staining shows that the fish muscle satellite cells are differentiated into a neat arrangement in the fibrin hydrogel of myotubes.

对比例1Comparative example 1

本对比例所述同实施例1相似,其区别在于,不采用硅胶模型进行培养,而是取30μL实施例1中细胞-纤维蛋白原悬液以滴状添加到48孔板中进行后续培养。This comparative example is similar to that in Example 1, the difference being that instead of using a silica gel model for culture, 30 μL of the cell-fibrinogen suspension in Example 1 was added dropwise into a 48-well plate for subsequent culture.

本对比施例培养所得的圆滴状水凝胶包埋细胞如图1中的B。分化第七天的细胞-纤维蛋白水凝胶的免疫荧光染色图如图5所示,结蛋白/细胞核染色可以看出鱼肌卫星细胞在纤维蛋白水凝胶中分化形成了肌管,但是肌管呈异向性,杂乱无章的分布。这与使用硅胶模型所培养的细胞形成的肌管有很大的区别。因此,本发明所采用的方法能很好地形成具有同向排列分布的肌管,更接近真实肉类的肌管组织。The drop-shaped hydrogel-embedded cells cultured in this comparative example are shown in B in Figure 1 . The immunofluorescence staining image of cells-fibrin hydrogel on the seventh day of differentiation is shown in Figure 5. Desmin/nucleus staining shows that fish muscle satellite cells have differentiated into myotubes in fibrin hydrogel, but muscle The tubes are anisotropic and distributed randomly. This is quite different from the myotubes formed by cells cultured using silica models. Therefore, the method adopted in the present invention can well form myotubes arranged in the same direction, which is closer to the myotube tissue of real meat.

对比例2Comparative example 2

本对比例所述同实施例1相似,其区别有两点,第一是不采用硅胶模型进行培养,而是取30μL细胞-纤维蛋白原悬液以滴状添加到48孔板中进行后续培养;第二是细胞-纤维蛋白原悬液中的细胞浓度为7.0×106个/mL。This comparative example is similar to that in Example 1, with two differences. The first is that the silica gel model is not used for culture, but 30 μL of cell-fibrinogen suspension is added to a 48-well plate in a drop form for subsequent culture. ; The second is that the cell concentration in the cell-fibrinogen suspension is 7.0×10 6 cells/mL.

本对比施例分化第七天的细胞-纤维蛋白水凝胶的免疫荧光染色图如图6所示。虽然改变了细胞浓度,但是细胞形成的肌管仍然是无序排列的。The immunofluorescence staining image of the cell-fibrin hydrogel on the seventh day of differentiation in this comparative example is shown in FIG. 6 . Although the cell concentration was changed, the myotubes formed by the cells were still arranged in disorder.

对比例3Comparative example 3

本对比例所述同实施例2相似,其区别是细胞-纤维蛋白原悬液中的细胞浓度为3.0×106个/mL。This comparative example is similar to that in Example 2, except that the cell concentration in the cell-fibrinogen suspension is 3.0×10 6 cells/mL.

本对比施例分化第七天的细胞-纤维蛋白水凝胶的免疫荧光染色图如图7所示。将细胞浓度降低在优选的范围内,虽然也能形成肌管,但是与实施例2相比形成的多核肌管数量少、长度短,排列效果不佳。The immunofluorescence staining image of the cell-fibrin hydrogel on the seventh day of differentiation in this comparative example is shown in FIG. 7 . When the cell concentration is reduced within the preferred range, although myotubes can also be formed, compared with Example 2, the number of multinucleated myotubes formed is small, the length is short, and the arrangement effect is not good.

以上是对本发明所作的进一步详细说明,不可视为对本发明的具体实施的局限。对于本发明所属技术领域的普通技术人员来说,在不脱离本发明构思的简单推演或替换,都在本发明的保护范围之内。The above is a further detailed description of the present invention, and should not be regarded as a limitation to the specific implementation of the present invention. For those of ordinary skill in the technical field to which the present invention belongs, simple deduction or replacement without departing from the concept of the present invention is within the protection scope of the present invention.

Claims (10)

1.一种模具,其特征在于,包括凹槽和竖向插入所述凹槽两端的针形组件。1. A mold, characterized in that it comprises a groove and a needle assembly vertically inserted into two ends of the groove. 2.根据权利要求1所述的模具,其特征在于,所述凹槽的材质包括硅胶;所述凹槽的形状包括U型。2. The mold according to claim 1, wherein the material of the groove comprises silica gel; the shape of the groove comprises a U shape. 3.根据权利要求1所述的模具,其特征在于,所述针形组件包括大头针;所述针形组件的间距为3~9mm。3 . The mold according to claim 1 , wherein the needle-shaped components comprise pins; and the distance between the needle-shaped components is 3-9 mm. 4 . 4.一种肌肉干细胞排列生长的方法,其特征在于,包括以下步骤:4. A method for the growth of muscle stem cells, comprising the following steps: 1)将肌肉干细胞的细胞悬液、预凝胶基质和凝血酶混合,得到混合悬液;1) mixing the cell suspension of the muscle stem cells, the pregel matrix and thrombin to obtain a mixed suspension; 2)将所述混合悬液加入到无菌的权利要求1~3任意一项所述的模具中,凝固形成细胞纤维蛋白水凝胶;2) adding the mixed suspension into the aseptic mold according to any one of claims 1 to 3, solidifying to form cell fibrin hydrogel; 3)在所述细胞纤维蛋白水凝胶中加入增殖培养基,进行细胞培养;3) adding a proliferation medium to the cell fibrin hydrogel for cell culture; 所述预凝胶基质以DMEM高糖培养基为基础,还包含纤维蛋白原和抗生素。The pregel matrix is based on DMEM high glucose medium and also contains fibrinogen and antibiotics. 5.根据权利要求4所述的方法,其特征在于,所述混合悬液中纤维蛋白原的浓度为8~10mg/mL。5. The method according to claim 4, characterized in that the concentration of fibrinogen in the mixed suspension is 8-10 mg/mL. 6.根据权利要求4或5所述的方法,其特征在于,所述混合悬液中肌肉干细胞的浓度为4×106~9×106个/mL;所述混合悬液中凝血酶的浓度为4~5U/mL。6. The method according to claim 4 or 5, characterized in that the concentration of muscle stem cells in the mixed suspension is 4×10 6 to 9×10 6 cells/mL; the thrombin in the mixed suspension The concentration is 4~5U/mL. 7.根据权利要求4所述的方法,其特征在于,所述抗生素包括青霉素G钠盐和硫酸链霉素;所述预凝胶基质中青霉素G钠盐的浓度为100U/mL;所述预凝胶基质中硫酸链霉素的浓度为0.1mg/mL。7. method according to claim 4, is characterized in that, described antibiotic comprises penicillin G sodium salt and streptomycin sulfate; The concentration of penicillin G sodium salt is 100U/mL in the described pregel matrix; The concentration of streptomycin sulfate in the gel matrix was 0.1 mg/mL. 8.根据权利要求4所述的方法,其特征在于,所述凝固的条件包括:温度为25~27℃,CO2的体积浓度为4%~6%,时间为20~60min。8 . The method according to claim 4 , wherein the coagulation conditions include: the temperature is 25-27° C., the volume concentration of CO 2 is 4%-6%, and the time is 20-60 minutes. 9.根据权利要求4所述的方法,其特征在于,所述细胞培养的温度为25~27℃;所述细胞培养的CO2的体积浓度为4%~6%;所述细胞培养包括依次进行的增殖培养和分化培养;所述增殖培养的时间为3~5d;所述分化培养的时间为6~8d。9. method according to claim 4 is characterized in that, the temperature of described cell culture is 25~27 ℃; The volume concentration of the CO of described cell culture is 4%~6%; Described cell culture comprises successively Proliferation culture and differentiation culture are carried out; the time of the proliferation culture is 3-5 days; the time of the differentiation culture is 6-8 days. 10.权利要求1~3任意一项所述的模具或者权利要求4~9任意一项所述的方法在制备细胞培养肉中的应用。10. Application of the mold according to any one of claims 1 to 3 or the method according to any one of claims 4 to 9 in the preparation of cell culture meat.
CN202310781190.4A 2023-06-29 2023-06-29 A mold and a method for arraying and growing muscle stem cells and their application Pending CN116555033A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310781190.4A CN116555033A (en) 2023-06-29 2023-06-29 A mold and a method for arraying and growing muscle stem cells and their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310781190.4A CN116555033A (en) 2023-06-29 2023-06-29 A mold and a method for arraying and growing muscle stem cells and their application

Publications (1)

Publication Number Publication Date
CN116555033A true CN116555033A (en) 2023-08-08

Family

ID=87493173

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310781190.4A Pending CN116555033A (en) 2023-06-29 2023-06-29 A mold and a method for arraying and growing muscle stem cells and their application

Country Status (1)

Country Link
CN (1) CN116555033A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113508172A (en) * 2019-03-04 2021-10-15 日清食品控股株式会社 Three-dimensional muscle tissue and method of making the same
CN118879622A (en) * 2024-09-27 2024-11-01 浙江大学 Culture medium and method for producing cell cultured meat by co-culturing myoblasts from different fish

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113508172A (en) * 2019-03-04 2021-10-15 日清食品控股株式会社 Three-dimensional muscle tissue and method of making the same
CN113508172B (en) * 2019-03-04 2024-12-03 日清食品控股株式会社 Three-dimensional muscle tissue and method for manufacturing the same
CN118879622A (en) * 2024-09-27 2024-11-01 浙江大学 Culture medium and method for producing cell cultured meat by co-culturing myoblasts from different fish
CN118879622B (en) * 2024-09-27 2025-03-11 浙江大学 Culture medium and method for co-culturing myoblasts of different fishes to produce cell culture meat

Similar Documents

Publication Publication Date Title
CN116555033A (en) A mold and a method for arraying and growing muscle stem cells and their application
Geissler et al. Biomimetic hydrogels direct spinal progenitor cell differentiation and promote functional recovery after spinal cord injury
Legato Ultrastructural characteristics of the rat ventricular cell grown in tissue culture, with special reference to sarcomerogenesis
Kadim et al. Cultured meat from muscle stem cells: A review of challenges and prospects
CN106039419B (en) Biological brick for biometric print and application thereof
CN103828763B (en) A kind of liver cancer patient source xenograft tumor mouse model and construction method thereof
CN103100112B (en) Preparation method and use of graft material in double membrane structure
DE10026789B4 (en) Cartilage replacement and process for its manufacture
CN112189050B (en) Apparatus and method for producing tissue from cells
Shah et al. Development of a novel smart scaffold for human skeletal muscle regeneration
CN114854677B (en) Microfluidic bionic fiber for cell culture meat production and preparation method and application thereof
CN104292497B (en) A kind of preparation method of recombination human source collagen bio-sponge
CN109689072A (en) Sperm activating agent and application thereof
KR20230034115A (en) Porous scaffold containing plant protein and cultured meat prepared using the same
CN112251352A (en) Special culture device for 3D biological tissue and preparation method of blocky cultured meat
US20240148034A1 (en) Constructs comprising fibrin or other blood products for meat cultivation and other applications
CN108310463A (en) 3D printing biological ink and preparation method thereof
Noor et al. Newer trends and techniques adopted for manufacturing of In vitro meat through “tissue-engineering” technology: a review
CN111304168B (en) Three-dimensional bioprinted in vivo tumor model and its construction method
CN117653790B (en) A tissue engineering artificial blood vessel and its preparation method and application
US20190038807A1 (en) Tissue engineering
Reddy et al. Cultured meat–a review
CN105255814B (en) A kind of preparation method of the chondrocyte induction substrate for micro-fracture operation
CN1218109A (en) Production of organs for transplantation and method and apparatus for renovation and restoration
KR20130102506A (en) Use of tissue and cell derived from mature cystic teratoma

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination